Skip to content
Screener

Veradermics MANE Q4 2025 Annual earnings

Reported February 25, 2026

EPS-$1.63Beat by $0.19
EPS estimate-$1.81

Next report

Nov 10, 2026 (in 2 months)
EPS estimate-$0.59

Financials

Q4 2025

Balance sheet

See full
Cash & equivalents$21.8M-59.0%
Total debt$4.0K
Total equity-$121.0M-150%
Total assets$152.6M+175%

Versus estimates

FAQ

When did Veradermics report Q4 2025 earnings?
Veradermics (MANE) reported Q4 2025 earnings on February 25, 2026.
What were Veradermics's Q4 2025 revenue and EPS?
Veradermics reported eps of $-1.63 for Q4 2025.
Did Veradermics beat estimates in Q4 2025?
EPS beat the consensus estimate of $-1.81 by $0.19.
How did Veradermics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 53.2% from $-1.06.
Where can I find Veradermics's Q4 2025 SEC filings?
You can read the 10-K periodic report (0001827635-26-000013) directly on SEC EDGAR. The filing index links above go to sec.gov.